1. Achieving end-to-end success in the clinic: Pfizer's learnings on R&D productivity. Issue 3 (March 2022) Authors: Fernando, Kathy; Menon, Sandeep; Jansen, Kathrin; Naik, Prakash; Nucci, Gianluca; Roberts, John; Wu, Shuang Sarah; Dolsten, Mikael Journal: Drug discovery today Issue: Volume 27:Issue 3(2022) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and value. Issue 10 (October 2021) Authors: Prigodich, Andrew E.; Wang, Shuntai; Verhoest, Patrick; Warne, Nicholas; Allerton, Charlotte; Burkhardt, John; Fernando, Kathy; Dolsten, Mikael Journal: Drug discovery today Issue: Volume 26:Issue 10(2021) Page Start: 2232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reviving an R&D pipeline: a step change in the Phase II success rate. Issue 2 (February 2021) Authors: Wu, Shuang S.; Fernando, Kathy; Allerton, Charlotte; Jansen, Kathrin U.; Vincent, Michael S.; Dolsten, Mikael Journal: Drug discovery today Issue: Volume 26:Issue 2(2021) Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗